Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focusing on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders, are seeing a huge rally in trading today.
Continue reading Major Gainers and Losers on November 27; ACAD, MMR, CROX, THO, DDS